S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

bioAffinity Technologies Secures $4 Million in Private Placement

With a strategic move to bolster capital, New Jersey-based bioAffinity Technologies has finalized a private placement deal expected to generate $4 million. The biotechnology firm, which specializes in noninvasive cancer diagnostics, is issuing over 8.4 million shares and accompanying warrants to an institutional investor to fund its operations.

bioAffinity Technologies Secures $4 Million in Private Placement
Photo: Bio & News

The offering, priced at-the-market under Nasdaq regulations, carries a combined effective price of $0.4727 per share and two warrants. Pre-funded warrants included in the deal are priced at $0.4657, with an exercise price of $0.007. The warrants are set to expire in five years, pending necessary shareholder approval.

WallachBeth Capital LLC served as the sole placement agent for the transaction. The company expects the deal to close by August 14, 2026, provided standard closing conditions are met. These securities are being issued under Section 4(a)(2) of the Securities Act and are not currently registered for public resale.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!